Ocular Manifestations of Systemic Lupus Erythematosus: a Review of the Literature Neal V

Total Page:16

File Type:pdf, Size:1020Kb

Ocular Manifestations of Systemic Lupus Erythematosus: a Review of the Literature Neal V Ocular Manifestations of Systemic Lupus Erythematosus: A Review of the Literature Neal V. Palejwala, Emory University Harpreet S. Walia, Emory University Steven Yeh, Emory University Journal Title: Autoimmune Diseases Volume: Volume 2012, Number 2012 Publisher: Hindawi Publishing Corporation | 2012-05-31, Pages 1-9 Type of Work: Article | Final Publisher PDF Publisher DOI: 10.1155/2012/290898 Permanent URL: http://pid.emory.edu/ark:/25593/d8q18 Final published version: http://www.hindawi.com/journals/ad/2012/290898/ Copyright information: © 2012 Neal V. Palejwala et al. This is an Open Access work distributed under the terms of the Creative Commons Attribution 3.0 Unported License (http://creativecommons.org/licenses/by/3.0/). Accessed September 23, 2021 5:51 AM EDT Hindawi Publishing Corporation Autoimmune Diseases Volume 2012, Article ID 290898, 9 pages doi:10.1155/2012/290898 Review Article Ocular Manifestations of Systemic Lupus Erythematosus: A Review of the Literature Neal V. Palejwala, Harpreet S. Walia, and Steven Yeh Section of Vitreoretinal Disease and Surgery, Department of Ophthalmology, Emory Eye Center, Emory University School of Medicine, Atlanta, 30322 GA, USA Correspondence should be addressed to Steven Yeh, [email protected] Received 5 May 2012; Accepted 31 May 2012 Academic Editor: Hiroshi Okamoto Copyright © 2012 Neal V. Palejwala et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. About one-third of patients suffering from systemic lupus erythematosus have ocular manifestations. The most common manifestation is keratoconjunctivitis sicca. The most vision threatening are retinal vasculitis and optic neuritis/neuropathy. Prompt diagnosis and treatment of eye disease is paramount as they are often associated with high levels of systemic inflammation and end-organ damage. Initial management with high-dose oral or IV corticosteroids is often necessary. Multiple “steroid-sparing” treatment options exist with the most recently studied being biologic agents. 1. Introduction as alleles that cause deficiency in complement components— C1q, C2, and C4 [5]—have all been linked to lupus. Systemic lupus erythematosus (SLE) is a chronic, autoim- mune, connective tissue disorder affecting multiple organ systems often with a relapsing and remitting clinical course. 3. Mechanism of Disease Prevalence, clinical manifestations, and morbidity vary sig- nificantly between the developing and industrialized worlds. SLE is a complex disease process demonstrating dysregula- While SLE is more common in people of African and Asian tion of the immune system at multiple levels. Autoantibodies descent, thrombotic complications are more common in against double-stranded DNA were first isolated from kidney Caucasian patients [1]. The highest prevalence has been specimens in patients with lupus nephritis in 1967 [6]. reported in Italy, Spain, Martinique, and the UK Afro- Other autoantibodies that have been implicated in disease Caribbean population [2]. The median age of onset is include anti-Ro, La, Sm, nucleosome, NMDA receptor, between the late teens and early 40s with a 9 times phospholipid, and α-actinin. Two major theories exist on higher incidence in women compared to men. Ocular how these autoantibodies cause tissue damage. The first manifestations—occurring in up to one third of patients— model suggests that anti-double-stranded DNA antibodies can be associated with significant morbidity and also a bind to circulating nucleosomes to form immune complexes marker for overall systemic disease activity. that then get deposited in end-organ capillary beds such as the renal glomerulus and activate immune/inflammatory responses [7]. The second hypothesizes that these autoanti- 2. Genetic Considerations bodies cross-react with normal renal proteins causing tissue destruction [8]. The source of autoantigens that trigger Concordance rates for SLE among monozygotic and dizy- the formation of the aforementioned antibodies is thought gotic twins are 25% and 2%, respectively, suggesting a sig- to arise from apoptotic cells. Normally, early complement nificant genetic contribution [3]. Major histocompatibility factors, such as C1q, bind cellular debris from apoptotic cells, complex genes, such as HLA-A1, B8, and DR3 [4], as well which facilitate phagocytosis by macrophages. Deficiency of 2 Autoimmune Diseases such complement factors is an independent risk factor for the Subcutaneous inflammation secondary to SLE was first development of SLE [5]. described by Kaposi in 1883, and the term “lupus ery- Mass production of autoantibodies relies on multiple fac- thematosus panniculitis” was coined in 1940 [14]. It is tor, which have each independently been targeted as potential most commonly encountered in the setting of discoid lupus immunotherapy in the treatment of lupus. Important steps erythematosus. Clinical findings include tender deep subcu- include T-cell activation via antigen binding to the T-cell taneous nodules usually involving the proximal extremities, receptor and proper costimulation; T-cell activation of B trunk, face, and scalp [15]. Orbital involvement is very cells; production of cytokines such as TNF-α,INF-γ, IL-10, rare and has only been reported in a handful of paper. and B-lymphocyte stimulator. Histopathology shows perivascular lymphocytic infiltration Medications, hormonal influences, and other factors [16]. Response to steroids can be quite dramatic in most such as sunlight have all been implicated in disease exac- cases [16–18]; however, few cases have shown a more erbation. Drug-induced lupus, most commonly due to virulent course with significant enophthalmos secondary to procainamide, hydralazine, and quinidine, usually presents fat atrophy [19] and even melting of orbital structures [20]. with disease involving the skin and joints with renal and CNS manifestations being much more rare [9]. Hormonal 5.2. Periorbita. Periorbital edema is an uncommon mani- replacement therapy has been associated with an increased festation of systemic and discoid lupus erythematosus with risk of mild-to-moderate flares [10]. an overall incidence of 4.8% [21]. It is most common in patients of African decent [22]. Violaceous swelling with overlying eczematous changes without any skin necrosis 4. Diagnostic Criteria is seen. Some cases can resemble chronic blepharitis [23]. Etiologies include nephrosis, increased vascular permeabil- According to the 1982 revised criteria for systemic lupus ity, dermal mucin deposits, and angioedema secondary erythematosus, a diagnosis of SLE can be made by the serial to C1 deficiency. Treatment options include observation or simultaneous presentation of at least 4 of the following [23], topical/intradermal/systemic corticosteroids [24], and 11 criteria: malar rash, discoid rash, photosensitivity, oral antimalarials [23]. ulcers, nonerosive arthritis, serositis, renal dysfunction, neu- rological derangements (i.e., seizures or psychosis), hemato- logic disorder (i.e., anemia, leukopenia, thrombocytopenia), 5.3. Eyelids. Typical lesions of discoid lupus erythematosus immunologic disorder (i.e., anti-DNA antibody, anti-Sm are slightly raised, scaly, and atrophic. Most commonly, they antibody, and false positive VDRL testing), and presence of occur on the head, face, neck, and other sun-exposed areas. ff antinuclear antibodies. Rarely does it a ect the eyelids. Histopathologic study shows a hyperkeratotic epithelium with liquefactive degeneration of the basal layer and a dense perivascular/periappendageal 5. Ocular Manifestations lymphocytic infiltration [25, 26]. Diagnosis in most cases ff is delayed because lesions are often mistaken for blephar- SLE can a ect the periorbita, ocular adnexa, eye, and optic itis and eczema. Patients most commonly present with nerve. The most common association is keratoconjunctivitis chronic erythema, blepharoconjunctivitis with inflammation sicca, while the most visually devastating sequelae occur of the meibomian glands. Long-term complications include secondary to optic nerve involvement and retinal vaso- madarosis, lid scarring, and cicatricial ectropion/entropion occlusion. [26, 27]. 5.1. Orbit. Orbital involvement is a rare manifestation of 5.4. Ocular Surface. The most common ocular manifestation SLE. Vasculitis, myositis, and panniculitis have all been of SLE is keratoconjunctivitis sicca with the majority of described. Signs and symptoms include proptosis, enoph- patients endorsing at least one dry eye symptom [28]. thalmos, orbital pain, blurred vision, chemosis, and restric- Dryness can occur from multiple etiologies. Most patients tion of extraocular movements. with SLE develop a secondary Sjogren’s syndrome. In their Orbital vasculitis leads to nonperfusion of the globe review of 283 SLE patients, Manoussakis et al. [29] identified and extraocular muscles. This has been shown to cause 9.2% who had developed Sjogren’s syndrome (SS). The SLE- irreversible vision loss secondary to ischemic injury to the SS group had a higher frequency of Raynaud’s phenomenon, optic nerve as well as elevated intraocular pressure from anti-Ro antibody, anti-La antibody, and rheumatoid factor neovascular glaucoma [11]. and a lower frequency of renal involvement, lymphadenopa- Orbital myositis is often initially misdiagnosed as bac- thy, and thrombocytopenia. These patients tend to undergo terial orbital cellulitis, as it usually presents
Recommended publications
  • Differentiate Red Eye Disorders
    Introduction DIFFERENTIATE RED EYE DISORDERS • Needs immediate treatment • Needs treatment within a few days • Does not require treatment Introduction SUBJECTIVE EYE COMPLAINTS • Decreased vision • Pain • Redness Characterize the complaint through history and exam. Introduction TYPES OF RED EYE DISORDERS • Mechanical trauma • Chemical trauma • Inflammation/infection Introduction ETIOLOGIES OF RED EYE 1. Chemical injury 2. Angle-closure glaucoma 3. Ocular foreign body 4. Corneal abrasion 5. Uveitis 6. Conjunctivitis 7. Ocular surface disease 8. Subconjunctival hemorrhage Evaluation RED EYE: POSSIBLE CAUSES • Trauma • Chemicals • Infection • Allergy • Systemic conditions Evaluation RED EYE: CAUSE AND EFFECT Symptom Cause Itching Allergy Burning Lid disorders, dry eye Foreign body sensation Foreign body, corneal abrasion Localized lid tenderness Hordeolum, chalazion Evaluation RED EYE: CAUSE AND EFFECT (Continued) Symptom Cause Deep, intense pain Corneal abrasions, scleritis, iritis, acute glaucoma, sinusitis, etc. Photophobia Corneal abrasions, iritis, acute glaucoma Halo vision Corneal edema (acute glaucoma, uveitis) Evaluation Equipment needed to evaluate red eye Evaluation Refer red eye with vision loss to ophthalmologist for evaluation Evaluation RED EYE DISORDERS: AN ANATOMIC APPROACH • Face • Adnexa – Orbital area – Lids – Ocular movements • Globe – Conjunctiva, sclera – Anterior chamber (using slit lamp if possible) – Intraocular pressure Disorders of the Ocular Adnexa Disorders of the Ocular Adnexa Hordeolum Disorders of the Ocular
    [Show full text]
  • Eyelid and Orbital Infections
    27 Eyelid and Orbital Infections Ayub Hakim Department of Ophthalmology, Western Galilee - Nahariya Medical Center, Nahariya, Israel 1. Introduction The major infections of the ocular adnexal and orbital tissues are preseptal cellulitis and orbital cellulitis. They occur more frequently in children than in adults. In Schramm's series of 303 cases of orbital cellulitis, 68% of the patients were younger than 9 years old and only 17% were older than 15 years old. Orbital cellulitis is less common, but more serious than preseptal. Both conditions happen more commonly in the winter months when the incidence of paranasal sinus infections is increased. There are specific causes for each of these types of cellulitis, and each may be associated with serious complications, including vision loss, intracranial infection and death. Studies of orbital cellulitis and its complication report mortality in 1- 2% and vision loss in 3-11%. In contrast, mortality and vision loss are extremely rare in preseptal cellulitis. 1.1 Definitions Preseptal and orbital cellulites are the most common causes of acute orbital inflammation. Preseptal cellulitis is an infection of the soft tissue of the eyelids and periocular region that is localized anterior to the orbital septum outside the bony orbit. Orbital cellulitis ( 3.5 per 100,00 ) is an infection of the soft tissues of the orbit that is localized posterior to the orbital septum and involves the fat and muscles contained within the bony orbit. Both types are normally distinguished clinically by anatomic location. 1.2 Pathophysiology The soft tissues of the eyelids, adnexa and orbit are sterile. Infection usually originates from adjacent non-sterile sites but may also expand hematogenously from distant infected sites when septicemia occurs.
    [Show full text]
  • Department of Ophthalmology Medical Faculty of Padjadjaran University Cicendo Eye Hospital, the National Eye Center Bandung
    1 DEPARTMENT OF OPHTHALMOLOGY MEDICAL FACULTY OF PADJADJARAN UNIVERSITY CICENDO EYE HOSPITAL, THE NATIONAL EYE CENTER BANDUNG Case report : Clinical features and Diagnosis of Neuromyelitis Optica Spectrum Disorder (NMOSD) Presenter : Lucy Nofrida Siburian Supervisor : DR. Bambang Setiohaji, dr., SpM(K)., MH.Kes Has been reviewed and approved by supervisor of neuro-ophthalmology unit DR. Bambang Setiohaji, dr., SpM(K)., MH.Kes Friday, August 04, 2017 07.00 am 2 Abstract Introduction : Neuromyelitis optica spectrum disorder (NMOSD), previously known as Devic’s disease, is an inflammatory CNS syndrome distinct from multiple sclerosis (MS). It is characterized by severe, immune-mediated demyelination and axonal damage predominantly targeting the optic nerves and spinal cord though rarely the brain is also involved. Most patients with NMO and many with NMOSD have autoantibodies against the water channel aquaporin-4(AQP4-Ab), which are thought to be pathogenic. However, some patients are seronegative for AQP4-Abs and the lack of a biomarker makes diagnosis and management of these patients difficult. Aim : To present an NMO case and to know the current diagnosis criteria of NMOSD Case report : A woman, 42 years old, came to neuro-ophthalmology unit of Cicendo eye hospital on March 14, 2017 with sudden blurred vision on the right eye (RE) two days before admission without eye movement pain. Physical examination and body weight were normal. Visual acuity (VA) of the right eye (RE) was 1/300 and the best corrected VA on the left eye was 1.0. Anterior segment on the RE showed relative afferent pupillary defect grade 3 (RAPD), others were normal and so is on the LE.
    [Show full text]
  • Diagnosing, Treating, and Managing Scleritis in 2020 an Expert Panel Recommendation Panel Members Melissa Toyos, Md Stephen D
    DIAGNOSING, TREATING, AND MANAGING SCLERITIS IN 2020 AN EXPERT PANEL RECOMMENDATION PANEL MEMBERS MELISSA TOYOS, MD STEPHEN D. ANESI, MD, FACS n Partner and Director of Research n Massachusetts Eye Research & Surgery Institution n Toyos Clinic n Waltham, MA n Nashville, TN DAVID S. CHU, MD n Medical Director, Metropolitan Eye Research THOMAS A. ALBINI, MD & Surgery Institute n Professor of Clinical Ophthalmology n Associate Professor of Clinical Ophthalmology n University of Miami Health n Rutgers University n Bascom Palmer Eye Institute n Newark, NJ n Miami, FL ROBERT C. WANG, MD n Texas Retina Associates n Dallas, TX Corresponding Author: Melissa Toyos, MD; Toyos Clinic, Nashville, TN; [email protected]. This work was supported by an unrestricted medical writing grant from Mallinckrodt Pharmaceuticals and is based on a virtual roundtable discussion hosted by Evolve Medical Education LLC. Although uncommon, scleritis is a dangerous immune-me- DIAGNOSING SCLERITIS diated disease that can potentially threaten the structural Melissa Toyos, MD: What percentage of patients in integrity of the eye and may be indicative of potentially your practice have scleritis? life-threatening systemic vasculitis.1,2 Data on the genetic factors of scleritis is lacking, but it is thought that genes affect- Stephen D. Anesi, MD, FACS: Scleritis accounts for 10% ing systemic autoimmune diseases impact scleritis as well.2 to 15% of the patients I see in my practice. Differentiating between episcleritis and scleritis and posterior and anterior scleritis can be challenging for physicians. An David S. Chu, MD: I agree; 10% to 15% sounds right to accurate diagnosis is critical to properly treat the disease and me as well.
    [Show full text]
  • Contrast Sensitivity Function in Graves' Ophthalmopathy and Dysthyroid Optic Neuropathy Br J Ophthalmol: First Published As 10.1136/Bjo.77.11.709 on 1 November 1993
    Britishjournal ofOphthalmology 1993; 77: 709-712 709 Contrast sensitivity function in Graves' ophthalmopathy and dysthyroid optic neuropathy Br J Ophthalmol: first published as 10.1136/bjo.77.11.709 on 1 November 1993. Downloaded from Maria S A Suttorp-Schulten, Rob Tijssen, Maarten Ph Mourits, Patricia Apkarian Abstract defocus greatly facilitates the process of subjec- Contrast sensitivity function was measured by tive refraction correction, but reduced contrast a computer automated method on 38 eyes with sensitivity at low spatial frequencies may present dysthyroid optic neuropathy and 34 eyes with with normal Snellen acuity. As there are various Graves' ophthalmopathy only. The results degrees ofvisual loss within the group ofpatients were compared with 74 healthy control eyes. with dysthyroid neuropathy, assessment of Disturbances of contrast sensitivity functions spatial vision across the frequency and contrast were found in both groups when compared with spectrum may reveal visual impairment not controls. The eyes affected with dysthyroid readily detected by standard visual acuity optic neuropathy showed pronounced loss of measures. contrast sensitivity in the low frequency range, The contrast sensitivity function has proved a which facilitates differentiation between the useful tool for detecting visual disturbances two groups. when Snellen acuity fails to show comparable (BrJ Ophthalmol 1993; 77: 709-712) dysfunction - for example, in glaucoma,'4 retinal disease,'516 and pterygia." The clinical potential for contrast sensitivity functions has also been Graves' ophthalmopathy is related to thyroid demonstrated in patients with optic neuro- disease and is characterised by oedema and pathies, " 2"02' including dysthyroid optic neuro- infiltration ofthe extraocular muscles and orbital pathy."22 This study compares the contrast tissue.
    [Show full text]
  • Eyelid Conjunctival Tumors
    EYELID &CONJUNCTIVAL TUMORS PHOTOGRAPHIC ATLAS Dr. Olivier Galatoire Dr. Christine Levy-Gabriel Dr. Mathieu Zmuda EYELID & CONJUNCTIVAL TUMORS 4 EYELID & CONJUNCTIVAL TUMORS Dear readers, All rights of translation, adaptation, or reproduction by any means are reserved in all countries. The reproduction or representation, in whole or in part and by any means, of any of the pages published in the present book without the prior written consent of the publisher, is prohibited and illegal and would constitute an infringement. Only reproductions strictly reserved for the private use of the copier and not intended for collective use, and short analyses and quotations justified by the illustrative or scientific nature of the work in which they are incorporated, are authorized (Law of March 11, 1957 art. 40 and 41 and Criminal Code art. 425). EYELID & CONJUNCTIVAL TUMORS EYELID & CONJUNCTIVAL TUMORS 5 6 EYELID & CONJUNCTIVAL TUMORS Foreword Dr. Serge Morax I am honored to introduce this Photographic Atlas of palpebral and conjunctival tumors,which is the culmination of the close collaboration between Drs. Olivier Galatoire and Mathieu Zmuda of the A. de Rothschild Ophthalmological Foundation and Dr. Christine Levy-Gabriel of the Curie Institute. The subject is now of unquestionable importance and evidently of great interest to Ophthalmologists, whether they are orbital- palpebral specialists or not. Indeed, errors or delays in the diagnosis of tumor pathologies are relatively common and the consequences can be serious in the case of malignant tumors, especially carcinomas. Swift diagnosis and anatomopathological confirmation will lead to a treatment, discussed in multidisciplinary team meetings, ranging from surgery to radiotherapy.
    [Show full text]
  • CAUSES, COMPLICATIONS &TREATMENT of A“RED EYE”
    CAUSES, COMPLICATIONS & TREATMENT of a “RED EYE” 8 Most cases of “red eye” seen in general practice are likely to be conjunctivitis or a superficial corneal injury, however, red eye can also indicate a serious eye condition such as acute angle glaucoma, iritis, keratitis or scleritis. Features such as significant pain, photophobia, reduced visual acuity and a unilateral presentation are “red flags” that a sight-threatening condition may be present. In the absence of specialised eye examination equipment, such as a slit lamp, General Practitioners must rely on identifying these key features to know which patients require referral to an Ophthalmologist for further assessment. Is it conjunctivitis or is it something more Iritis is also known as anterior uveitis; posterior uveitis is serious? inflammation of the choroid (choroiditis). Complications include glaucoma, cataract and macular oedema. The most likely cause of a red eye in patients who present to 4. Scleritis is inflammation of the sclera. This is a very rare general practice is conjunctivitis. However, red eye can also be presentation, usually associated with autoimmune a feature of a more serious eye condition, in which a delay in disease, e.g. rheumatoid arthritis. treatment due to a missed diagnosis can result in permanent 5. Penetrating eye injury or embedded foreign body; red visual loss. In addition, the inappropriate use of antibacterial eye is not always a feature topical eye preparations contributes to antimicrobial 6. Acid or alkali burn to the eye resistance. The patient history will usually identify a penetrating eye injury Most general practice clinics will not have access to specialised or chemical burn to the eye, but further assessment may be equipment for eye examination, e.g.
    [Show full text]
  • A Rare Presentation of Lower Conjunctival Fornix Eyelashes Cyst Dr Mohammad Aldroos (MD)* *Department of Ophthalmology, Jordanian Royal Medical Services
    Int J Biol Med Res.2018 ;9(1):6259-6260 Int J Biol Med Res www.biomedscidirect.com Volume 6, Issue 2, April 2015 Contents lists available at BioMedSciDirect Publications International Journal of Biological & Medical Research Journal homepage: www.biomedscidirect.com BioMedSciDirect International Journal of Publications BIOLOGICAL AND MEDICAL RESEARCH Case report A rare presentation of lower conjunctival fornix eyelashes cyst Dr Mohammad Aldroos (MD)* *Department of Ophthalmology, Jordanian Royal Medical Services A R T I C L E I N F O A B S T R A C T Keywords: Purpose: To describe a rare presentation of a right lower conjunctival fornix eyelashes cyst. Case Report: A 56 year-old lady presented to our clinic complaining of blackish mass in the lower conjunctival fornix of the right eye ( see fig.1), with mild conjunctival hyperemia around the mass. There was no history of discharge and difficulty in extraocular muscles movements also there was no history of trauma. A gradually enlarging mass over the past few years with recurrent conjunctivitis. Slit lamp examination of the mass showed normal appearing eyelashes surrounded by capsule only. The mass was surgically excised with good cosmetic appearance and without any complications c Copyright 2010 BioMedSciDirect Publications IJBMR - ISSN: 0976:6685. All rights reserved. Introduction Fig.2 Eyelashes grow on the edge of the eyelid. A normal eyelid has a single row of eyelashes located along its anterior margin. The posterior portion of the lid contains a row of Meibomian glands orifices, which secrete the oily component of the tear film (1). There are approximately 100 eye lashes on the upper lid and approximately 50-75 on the lower lid, they protect the eyeball.
    [Show full text]
  • Red Eye Sub-Conjunctival Hemorrhage
    AEP Course 1 Friday 1:00 - 2:00 pm Disclosures Red Eye • Consultant for Alcon Cecelia Koetting, OD FAAO Virginia Eye Consultants Norfolk, VA VOA Conference Norfolk 2018 Nothing makes the office more Multiple Causes of “Red Eye” nervous than when this walks in. • Sub-Conjunctival hemorrhage • Allergic Conjunctivitis • Viral Conjunctivitis • Bacterial Conjunctivitis • Episcleritis • Scleritis • Ocular Surface Disease How to Triage Sub-Conjunctival • On the phone • Get as much information as possible about which eye, Hemorrhage when, how, recent surgeries, recent trauma and what medications have been used • In the room • Gather the same information as well as details on symptoms • Help to avoid possible spread of bacterial and viral conjunctivitis 1 AEP Course 1 Friday 1:00 - 2:00 pm Causes • Straining from: • Broken blood vessel releasing blood into the • Coughing • Vomiting surrounding sub conjunctival tissue • Constipation • A bruise • Diarrhea • Lifting • More common in patients on blood thinners • Sneezing • Bruise more easily and will take longer to resolve • Rubbing the eyes • Contact lens • Severe dryness • Trauma, surgery, injections • Blood clotting disorders and blood thinners • Occasionally, high blood pressure High BP • Remember to ask if the patient is on blood thinners or blood pressure meds Allergic Conjunctivitis • Last time took BP meds • Possibly check BP in office if haven't taken • Inflammation in the lining of the conjunctiva from allergies • IgE and Mast Cell release • Symptoms: itching, redness, tearing, foreign body
    [Show full text]
  • Ophthalmic and Adnexal Complications of Radiotherapy
    Acta Ophthalmologica Scandinavica 2007 Review Article Ophthalmic and adnexal complications of radiotherapy Shane R. Durkin,1 Daniel Roos,2 Braden Higgs,2 Robert J. Casson1,3 and Dinesh Selva1,3 1Department of Ophthalmology and Visual Sciences, University of Adelaide, Royal Adelaide Hospital, Adelaide, South Australia, Australia 2Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia 3Department of Medicine and Surgery, University of Adelaide, Royal Adelaide Hospital, Adelaide South Australia, Australia ABSTRACT. The efficacy of radiotherapy is The role of radiotherapy in ophthalmic practice continues to grow. This determined by aspects of radiation growth has seen an expansion of indications for radiotherapy, a refinement of delivery and the biological conse- the modalities that can be used and a reduction in the ocular and adnexal com- quences to the tumour and normal tis- plications that result from this form of therapy. The compendium of indica- sues. By giving radiation doses over a tions for radiotherapy in ophthalmology continues to grow and now includes number of fractions, damage to nor- many conditions such as the treatment of lid and adnexal disease, ocular sur- mal tissues can be reduced due to the repair of sublethal damage between face disorders and both benign and malignant disease of the posterior segment fractions and repopulation of cells and optic pathways. The radiotherapeutic modalities employed to manage during the course of treatment. these conditions are numerous and include
    [Show full text]
  • Postoperative Eye Protection After Cataract Surgery Anterior Uveitis Responds to Ganciclovir, but the Relapse Rate Is High and Prolonged Therapy May Be Required
    Correspondence 1152 Sir, 4 Ioannidis AS, Bacon J, Frith P. Juxtapapillary cytomegalovirus Cytomegalovirus and Eye retinitis with optic neuritis. J Neuroophthalmol 2008; 28(2): 128–130. 5 Mansour AM. Cytomegalovirus optic neuritis. Curr Opin We read with interest the very comprehensive article Ophthalmol 1997; 8(3): 55–58. by Carmichael on cytomegalovirus (CMV) and eye.1 6 Patil AJ, Sharma A, Kenney MC, Kuppermann BD. In addition to the clinical features reported by the Valganciclovir in the treatment of cytomegalovirus retinitis author,1 we would like to highlight some additional in HIV-infected patients. Clin Ophthalmol 2012; 4: 111–119. salient clinical points associated with CMV and eye. With regard to clinical manifestation of CMV anterior R Agrawal uveitis, the iris atrophy is patchy or diffuse, with no posterior synechiae and no posterior segment changes.2 Department of Ophthalmology, Tan Tock Seng It is usually associated with increased intraocular Hospital, Singapore pressure.2 Chee and Jap3 also reported the presence of an E-mail: [email protected] immune ring in the cornea of patients with CMV anterior uveitis. Nodular endothelial lesions are white, medium- Eye (2012) 26, 1152; doi:10.1038/eye.2012.103; sized, nodular lesions surrounded by a translucent halo, published online 25 May 2012 which are significantly associated with CMV infection in cases of chronic anterior uveitis.2,3 Anterior uveitis with ocular hypertension resistant to topical steroid therapy and not clinically suggestive of the herpes group of Sir, virus makes the clinician suspect CMV infection.2 CMV Postoperative eye protection after cataract surgery anterior uveitis responds to ganciclovir, but the relapse rate is high and prolonged therapy may be required.
    [Show full text]
  • Pediatric Pharmacology and Pathology
    7/31/2017 In the next 2 hours……. Pediatric Pharmacology and Pathology . Ocular Medications and Children The content of th is COPE Accredited CE activity was prepared independently by Valerie M. Kattouf O.D. without input from members of the optometric community . Brief review of examination techniques/modifications for children The content and format of this course is presented without commercial bias and does not claim superiority of any commercial product or service . Common Presentations of Pediatric Pathology Valerie M. Kattouf O.D., F.A.A.O. Illinois College of Optometry Chief, Pediatric Binocular Vision Service Associate Professor Ocular Medications & Children Ocular Medications & Children . Pediatric systems differ in: . The rules: – drug excretion – birth 2 years old = 1/2 dose kidney is the main site of drug excretion – 2-3 years old = 2/3 dose diminished 2° renal immaturity – > 3 years old = adult dose – biotransformation liver is organ for drug metabolism Impaired 2° enzyme immaturity . If only 50 % is absorbed may be 10x maximum dosage Punctal Occlusion for 3-4 minutes ↓ systemic absorption by 40% Ocular Medications & Children Ocular Medications & Children . Systemic absorption occurs through….. Ocular Meds with strongest potential for pediatric SE : – Mucous membrane of Nasolacrimal Duct 80% of each gtt passing through NLD system is available for rapid systemic absorption by the nasal mucosa – 10 % Phenylephrine – Conjunctiva – Oropharynx – 2 % Epinephrine – Digestive system (if swallowed) Modified by variation in Gastric pH, delayed gastric emptying & intestinal mobility – 1 % Atropine – Skin (2° overflow from conjunctival sac) Greatest in infants – 2 % Cyclopentalate Blood volume of neonate 1/20 adult Therefore absorbed meds are more concentrated at this age – 1 % Prednisone 1 7/31/2017 Ocular Medications & Children Ocular Medications & Children .
    [Show full text]